BR112013019508A2 - purificação de insulina - Google Patents

purificação de insulina

Info

Publication number
BR112013019508A2
BR112013019508A2 BR112013019508A BR112013019508A BR112013019508A2 BR 112013019508 A2 BR112013019508 A2 BR 112013019508A2 BR 112013019508 A BR112013019508 A BR 112013019508A BR 112013019508 A BR112013019508 A BR 112013019508A BR 112013019508 A2 BR112013019508 A2 BR 112013019508A2
Authority
BR
Brazil
Prior art keywords
insulin peptide
insulin
protein
column
solid phase
Prior art date
Application number
BR112013019508A
Other languages
English (en)
Inventor
Jorgen M Mollerup
Soren Sondergaard Frederiksen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR112013019508A2 publication Critical patent/BR112013019508A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

purificação de insulina a presente invenção refere-se a um processo cromatográfico para separação de componentes de proteína de uma solução contendo proteína, a referida solução compreendendo um peptídeo de insulina e um ou mais íons de metal di ou polivalentes, o referido peptídeo de insulina senda capaz de autoassociação e/ou mudança estrutural na presença de íons de metal di- ou polivalentes, o referido processo compreendendo as etapas de: a) aplicação da solução contendo proteína a uma coluna de um material de fase sólida cromatográfico, em que a carga do peptídeo de insulina é de pelo menos 6,0 g por litro de volume de coluna (g/l<sym>); e b) eluição do peptídeo de insulina do referido material de fase sólida por meio de um eluente tendo um ph de no máximo 8,5; e coleta de um pool de peptídeo de insulina correspondendo e pelo menos 75% em peso do peptídeo de insulina aplicado à coluna na etapa (a).
BR112013019508A 2011-02-01 2012-02-01 purificação de insulina BR112013019508A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11152910 2011-02-01
US201161439544P 2011-02-04 2011-02-04
PCT/EP2012/051662 WO2012104339A1 (en) 2011-02-01 2012-02-01 Purification of insulin

Publications (1)

Publication Number Publication Date
BR112013019508A2 true BR112013019508A2 (pt) 2016-08-30

Family

ID=44514301

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013019508A BR112013019508A2 (pt) 2011-02-01 2012-02-01 purificação de insulina

Country Status (10)

Country Link
US (1) US9447163B2 (pt)
EP (1) EP2670773A1 (pt)
JP (1) JP6110312B2 (pt)
KR (1) KR20140007377A (pt)
CN (1) CN103459417B (pt)
AU (1) AU2012213432B2 (pt)
BR (1) BR112013019508A2 (pt)
MX (1) MX342922B (pt)
RU (1) RU2603752C2 (pt)
WO (1) WO2012104339A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
JP6755175B2 (ja) * 2013-03-20 2020-09-16 ノヴォ ノルディスク アー/エス インスリン投薬レジメン
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
US10155799B2 (en) 2014-07-21 2018-12-18 Merck Sharp & Dohme Corp. Chromatography process for purification of insulin and insulin analogs
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
CN108524539B (zh) * 2018-07-03 2019-04-02 扬子江药业集团广州海瑞药业有限公司 一种平衡盐冲洗液的药物组合物
CN111500563B (zh) * 2020-05-08 2023-10-13 华兰生物工程重庆有限公司 一种从人血浆中纯化人凝血因子ⅶ的方法
CN111518193B (zh) * 2020-06-11 2023-09-26 南京赛诺生物制药有限公司 一种脂肪酸酰化胰岛素和glp-1多肽的纯化方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2693434A (en) 1950-04-05 1954-11-02 Hoechst Ag Crystallized insulin preparation and process of preparing same
GB729670A (en) 1951-11-15 1955-05-11 Novo Terapeutisk Labor As Improved process for the production of insulin in crystalline form and crystalline insulin produced thereby
US3649456A (en) 1969-09-08 1972-03-14 Rohm & Haas Separation of polypeptide substances with macroreticular resins
US3907676A (en) 1970-07-28 1975-09-23 Novo Terapeutisk Labor As Process for purifying insulin
GB1581824A (en) 1976-01-16 1980-12-31 Leo Sa Lab Preparation of insulin
DE2629568C3 (de) 1976-07-01 1981-09-10 Hoechst Ag, 6000 Frankfurt Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
NL7713966A (nl) 1976-12-27 1978-06-29 Univ Minnesota Werkwijze voor het behandelen van insuline.
DE3511269A1 (de) 1985-04-12 1986-10-09 Veb Berlin-Chemie, Ddr 1199 Berlin Verfahren zur reinigung von insulin
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
US5122603A (en) 1989-03-08 1992-06-16 The University Of Virginia Alumni Patents Foundation Purified insulin mediators and purification process for same
US5278284A (en) 1992-05-14 1994-01-11 Miller Brewing Company Protein purification method
DE4406515C1 (de) 1994-02-28 1995-10-19 Immuno Ag Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
US5504188A (en) 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
WO1996040776A1 (en) * 1995-06-07 1996-12-19 Chiron Corporation Methods for purifying authentic igf from yeast hosts
AU5749198A (en) 1997-02-07 1998-08-26 Novo Nordisk A/S Crystallisation of proteins
RU2122549C1 (ru) 1997-12-29 1998-11-27 Закрытое акционерное общество "Фосфосорб" Способ хроматографического выделения и очистки белков, пептидов и их комплексов
ES2245824T3 (es) 1998-04-15 2006-01-16 Novo Nordisk A/S Nuevo proceso de separacion de proteinas utilizando un eluyente que contiene ca++.
US6451987B1 (en) 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
US20030216543A1 (en) 2001-05-16 2003-11-20 Wang Nien-Hwa Linda Insulin purification using simulated moving bed technology
DE10235168A1 (de) 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7608583B2 (en) 2002-12-05 2009-10-27 Wockhardt Limited Process for the extraction and isolation of insulin from recombinant sources
RU2251426C1 (ru) * 2003-09-18 2005-05-10 Цыганков Владимир Владимирович Способ получения инсулина из природного источника и инсулин
ES2391776T3 (es) * 2004-11-22 2012-11-29 Novo Nordisk A/S Formulaciones solubles, estables conteniendo insulina con una sal de protamina
PT1969004E (pt) * 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
US20100190210A1 (en) * 2006-03-20 2010-07-29 Medarex, Inc. Protein Purification
MX2008014061A (es) * 2006-05-09 2008-11-14 Novo Nordisk As Derivado de insulina.
RU2322504C1 (ru) 2006-06-26 2008-04-20 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Способ получения генно-инженерного инсулина человека
CN101173006B (zh) 2006-10-30 2011-12-21 江苏万邦生化医药股份有限公司 一种重组人胰岛素的制备方法
CA2666607C (en) 2006-11-01 2015-02-10 Biogen Idec Ma Inc. Method of isolating biomacromolecules using low ph and divalent cations
JP5552046B2 (ja) * 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー/エス インスリン誘導体を含有する薬学的製剤
EP2027875A1 (en) * 2007-08-23 2009-02-25 Octapharma AG A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC)
JP5715418B2 (ja) * 2007-11-08 2015-05-07 ノボ・ノルデイスク・エー/エス インスリン誘導体

Also Published As

Publication number Publication date
AU2012213432A1 (en) 2013-07-11
CN103459417B (zh) 2018-04-10
EP2670773A1 (en) 2013-12-11
MX342922B (es) 2016-10-19
AU2012213432B2 (en) 2016-10-13
JP2014504621A (ja) 2014-02-24
CN103459417A (zh) 2013-12-18
JP6110312B2 (ja) 2017-04-05
RU2013137811A (ru) 2015-03-10
MX2013008824A (es) 2013-10-07
WO2012104339A1 (en) 2012-08-09
US20140073759A1 (en) 2014-03-13
KR20140007377A (ko) 2014-01-17
US9447163B2 (en) 2016-09-20
RU2603752C2 (ru) 2016-11-27

Similar Documents

Publication Publication Date Title
BR112013019508A2 (pt) purificação de insulina
BR112015031196A2 (pt) “processo de purificação de anticorpo monoclonal”
BR112014015101A2 (pt) cromatografia de membrana de troca iônica
BRPI0611600B8 (pt) método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
BR112012024956A2 (pt) processo para a purificação de uma proteína de fator de crescimento
BR112016002092A2 (pt) Recuperação de glicosídeos de esteviol
BR112018003127A2 (pt) purificação de fkpa e usos do mesmo para produzir polipeptídeos recombinantes
Holstein et al. Improving selectivity in multimodal chromatography using controlled pH gradient elution
WO2017189357A3 (en) Charged surface reversed phase chromatographic materials method for analysis of glycans modified with amphipathic, strongly basic moieties
BR112015027812A2 (pt) processo contínuo de multietapa para purificação de anticorpos
BR112017018365A2 (pt) uso de lavagens alcalinas durante cromatografia para remoção de impurezas
BR112015018102A2 (pt) correção aperfeiçoada de perda de quadro na decodificação de um sinal
CU20170039A7 (es) Método de purificación del anticuerpo humanizado 9e4
BR112015017354A2 (pt) método para detectar pelo menos uma base modificada
BR112014000278A2 (pt) método para o preparo de um concentrado de imunoglobulinas polivalentes
BR112015025890A2 (pt) sistemas e métodos para separação unipolar de emulsões e outras misturas
BR112018016742A2 (pt) purificação de proteína
BR112012004697A2 (pt) purificação melhorada de proteína através de uma eluição da proteína a modificada.
WO2015104359A3 (en) Method for purifying cys-linked antibody-drug conjugates
BR112018001511A2 (pt) ?uso de solução aquosa com baixa condutividade e métodos de produção e purificação de anticorpo de isótipo igg1 ou igg4 humano
BR112017010069A2 (pt) redução seletiva de resíduos cisteína em anticorpos para il-17
BR112016001461A2 (pt) Método ou processo para modificar a fucosilação em um sistema de expressão de proteínas eucariótico e/ou eucariote, glicoproteína, e, uso de uma glicoproteína
AU2014370873A1 (en) Method for purifying antibody having low isoelectric point
BRPI0518925A2 (pt) partÍculas sàlidas provenientes da desestabilizaÇço controlada de microemulsÕes
EA201691834A1 (ru) Новый способ очистки гонадотропина

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2551 DE 26-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.